Schering-Plough Corp. faces a spate of federal court litigation over promotion of its drugs for uses not approved by the Food and Drug Administration.

Eight putative class action suits are pending with U.S. District Judge Stanley Chesler in Newark, N.J., consolidated by the U.S. Judicial Panel on Multidistrict Litigation on Aug. 16.